SUPERNUS PHARMACEUTICALS, INC. SUPN 48.16
Health Care · NASDAQ · Data as of 2026-10-29
SUPERNUS PHARMACEUTICALS, INC. (SUPN) has delivered +12.9% annualized revenue growth, n/a earnings growth, and n/a dividend growth over 10 years of data. Ranked #995 of 1968 stocks overall and #108 of 260 in the Health Care sector by Steady Score.
Industry
Pharmaceutical Preparations
Steady Score
48.16
Overall Rank
#995 / 1968
Sector Rank
#108 / 260
Revenue CAGR
+12.9%
Earnings CAGR
-
Dividend CAGR
-
?
E/R CAGR Ratio
-
Revenue
Earnings
Dividends
Free Cash Flow
Margin
NET Margin
FCF Margin
Payout Ratio
Payout Ratio
FCF Payout Ratio